Last updated July 1, 2022.

For patients with lymphoma, multiple myeloma and leukemia, CAR T cell therapy offers an effective treatment option when traditional treatment approaches fail – and then fail again.

Since the Food and Drug Administration (FDA) designated it a breakthrough therapy in 2014, this cellular therapy has become more widely available. And researchers have continued to push ahead to make CAR T cell therapy...